Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity

類似資料

• Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
  著者:: Morse, Michael A, 等
  出版事項: (2015)
• Novel Recombinant Alphaviral and Adenoviral Vectors for Cancer Immunotherapy
  著者:: Osada, Takuya, 等
  出版事項: (2012)
• Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
  著者:: Morse, Michael A., 等
  出版事項: (2008)
• Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
  著者:: Crosby, Erika J, 等
  出版事項: (2020)
• Induction of Wilms’ tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine
  著者:: Osada, Takuya, 等
  出版事項: (2009)